ABSTRACT TCDD (2, 3, 7, requires the presence of the aryl hydrocarbon receptor (Ahr) gene for its toxic effects, such as reproductive disorders in male offspring of maternally exposed rats and mice. To study the involvement of the Ahr gene in producing the toxic phenotype with respect to testicular development, we administered a relatively high dose of TCDD to mice with three different maternally derived Ahr genotypic traits, and then compared several Ahr-dependent alterations among male reproductive systems on Postnatal Day 14. Reduction in anogenital distance and expression of prostatic epithelial genes in the urogenital complex (UGC) were detected in Ahr +/+ and Ahr +/À mice exposed to TCDD, whereas no difference was observed in Ahr À/À mice. In situ hybridization revealed the absence of probasin mRNA expression in the prostate epithelium, despite the obvious development of prostatic lobes in TCDD-exposed mice. In contrast to obvious prostatic dysfunction and induction of cytochrome P450 (CYP) family genes in the UGC by TCDD, no alterations in testicular functions were observed in germ cell/Sertoli cell/interstitial cell marker gene expression or CYP family induction. No histopathological changes were observed among the three genotypes and between control and TCDD-exposed mice. Therefore, mouse external genitalia and prostatic development are much more sensitive to TCDD treatment than testis. Further, the Ahr gene, analyzed in this study, does not significantly contribute to testicular function during perinatal and immature stages, and the developing mouse testis appears to be quite resistant to TCDD exposure.
INTRODUCTION
TCDD (2,3,7,8-tetrachlorodebenzo-p-dioxin) is an extremely potent xenobiotic chemical. Maternal exposure to TCDD induces a wide range of physiological alterations and toxicities in the fetus and pups of laboratory animals and perhaps in humans [1] . TCDD induces various toxicological endpoints in male reproductive organs, such as decreased size of sexaccessory glands and reduced sperm counts in testis, epididymis, and ejaculate [2] [3] [4] [5] [6] [7] [8] [9] [10] . Although male rat and mouse offspring exposed to TCDD in utero can produce testicular androgen normally, the androgen responsiveness of the ventral prostate is lowered by unknown mechanisms of TCDD [9] [10] [11] [12] .
Interestingly, the effects of TCDD on testicular development and perinatal stage spermatogenesis are still unclear because the results are contradictory [2] [3] [4] [5] [6] [7] [8] [9] [10] . Some studies on testicular development that used conventional experimental animals reported the presence of slight reductions in testicular weight, daily sperm production, and steroidogenesis [2] [3] [4] [5] . On the other hand, clear negative data concerning the TCDD effect on testicular development were presented in many other papers [7] [8] [9] [10] . Taken together, the impairment in prostate development by in utero TCDD exposure appears to occur in many mammals, including rats and mice, but it is not understood whether or how susceptible the testicular development and perinatal stage spermatogenesis is to the TCDD exposure.
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that mostly mediates inductions of drugmetabolizing enzymes such as members of the CYP1A family, and it appears to act as a sensor for environmental contaminants such as dioxins and polyaromatic hydrocarbons [13, 14] . Experimental studies with Ahr gene knockout mice have already revealed that AHR plays an essential role in the occurrence of multiple TCDD-induced adverse effects, including teratogenic cleft palate and hydronephrosis [15, 16] . Reproductive disorders, such as prostatic growth impairment in male offspring following maternal exposure to TCDD, were also shown to be dependent on the Ahr gene [17] .
Some evidence also suggested that AHR was involved in developmental signaling in the immune and hepatic systems [18, 19] . In analyses using Ahr-null female mice, AHR was also required for normal ovarian germ cell dynamics, based on the observation that numbers of nonatretic primordial, primary, and small preantral follicles in ovaries of Ahr-null females at early postpartum stages were higher than those in wild-type mice [20] [21] [22] . Moreover, AHR cooperates with an orphan nuclear receptor, NR5A1 (also known as Ad4BP/SF-1), to activate P450 aromatase (CYP19) gene transcription in ovarian granulosa cells and modulate endogenous estrogen production in the female reproductive cycle [23] . AHR is also expressed in interstitial cells and male germ cells at specific stages [24] . More recently, AHR has been demonstrated to have a ubiquitin ligase activity, which enhances the degradation of estrogen and androgen receptors, suggesting that AHR may modulate androgen sensitivity in normal development [25] . To date, the possible involvement of AHR in testicular development during immature stages using AHR agonist administration or Ahr-null male mice has not been addressed.
To the best of our knowledge, this is the first study that used Ahr-null mice to investigate the involvement of the Ahr gene in early stages of testicular development and to assess the differences in susceptibility to in utero TCDD exposure between prostate and testicular development.
MATERIALS AND METHODS

Materials
TCDD was purchased from Cambridge Isotope Laboratory (Andover, MA). The purity was higher than 99.5%. Corn oil for dissolving TCDD or the control vehicle was obtained from Sigma-Aldrich (St. Louis, MO). TRIzol reagent, SuperScript III RNase H-Reverse Transcriptase, and oligo(dT)12-18 primer were purchased from Invitrogen (Carlsbad, CA). SYBR Premix Ex Taq (Perfect Real Time) was purchased from TAKARA BIO, Inc. (Otsu, Japan). The plasmid pGEM-TEasy vector was obtained from Promega Corp. (Madison, WI).
Animals and TCDD Administration
Ahr knockout mice were kindly provided by Dr. Yoshiaki Fujii-Kuriyama (Center for Tsukuba Advanced Research Alliance and Institute of Basic Medical Sciences, University of Tsukuba) [15] . They were bred in our own facility at the National Institute for Environmental Studies (NIES). All described procedures were approved by the NIES Institutional Animal Care and Use Committee and were performed in accordance with the Guidelines for Animal Experiments at the NIES. They were maintained in a controlled environment of temperature 24 6 18C, humidity 45 6 5%, and a 12L:12D cycle and were given food and distilled water ad libitum. Ahr heterozygous male mice were back-crossed with wild-type female C57BL/6J mice (CLEA Japan, Tokyo, Japan) six times, and heterozygous offspring of both sexes were used in this study. The heterozygous female mice (7-to 10-wk-old) were mated 1:1 with the heterozygous males overnight, and the females that had a vaginal plug on the following morning were designated as being pregnant at Gestational Day 0 (GD0). Dams were housed individually in clear plastic cages with heat-treated wood chips as bedding. On GD13, pregnant mice were given a single dose of TCDD orally (10 lg/kg body weight, close to a lethal dose for a C57BL/6J fetus) or an equivalent volume of vehicle (95% corn oil, 4% n-nonane; 5 ml/kg) as control. Male pups were killed under diethyl ether anesthesia on Postnatal Day 14 (PND14).
Sample Collection
On PND14, immediately before euthanization, the anogenital distance, determined by the length from the base of the genital tubercle to the anterior edge of the anus, was measured with a digital caliper. We also measured the crown-anal length (the distance between the nose and anterior edge of the anus). The testis and epididymis on both sides were excised from the abdomen, and the surrounding adipose tissue was carefully removed. After removing urine from the bladder, the deferent ducts were cut at the base of the bladder. The urogenital complex (UGC), which is a small mass comprising all the lobes of the prostate and seminal vesicle, was then collected by cutting the anterior end of the urethra. All tissue samples were frozen in liquid nitrogen immediately after dissection and kept at À808C until RNA extraction.
Real-Time RT-PCR
The protocols for real-time RT-PCR quantifications were described previously [26] . Briefly, total RNA was extracted from the UGC (n ¼ 5) and testis (n ¼ 3) using TRIzol reagent. RNA samples were reverse-transcribed with SuperScript III reverse transcriptase and oligo(dT)12-18 primer. Nineteen genes examined in this study: aryl hydrocarbon receptor (Ahr), cytochrome P450 1A1 (Cyp1a1), cytochrome P450 1A2 (Cyp1a2), cytochrome P450 1B1 (Cyp1b1), androgen receptor (Ar), steroid 5a-reductase type 1 (Srd5a1), steroid 5a-reductase type 2 (Srd5a2), probasin (Pbsn), Mp25 (Sbp), PSP94 (Msmb), calnexin-t (Clgn), Hsp70.2 (Hspa2), androgen-binding protein (Shbg), cytochrome P450 side chain cleavage (Cyp11a1), cytochrome P450 17a/C [17] [18] [19] [20] lyase (Cyp17a1), 3b-hydroxysteroid dehydrogenase type I (Hsd3b1), 3a-hydroxysteroid dehydrogenase type I (Akr1c4), 17b-hydroxysteroid dehydrogenase type III (Hsd17b3), and cyclophilin B (Ppib). All primer sets are shown in Supplemental Table S1 (available online at www.biolreprod.org). For the real-time RT-PCR, target genes were amplified with SYBR Premix Ex Taq (Perfect Real Time) system by using a LightCycler (Roche, Manheim, Germany). The relative expression level was calculated by normalizing with the average value of each control wild-type (Ahr þ=þ ) group. To determine the sequences, the PCR product for each gene was subcloned into pGEM-TEasy vectors or directly sequenced by the dideoxynucleotide chain termination method using the ABI Prism BigDye terminator cycle sequencing kit (PEBiosystems, Foster City, CA).
In Situ Hybridization
Mouse probasin mRNA was detected in the UGC specimens by in situ hybridization. The UGCs were fixed with neutralized formalin for 48 h, embedded in paraffin, and then cut into 4-lm sections. A template was amplified from the pGEM-TEasy vector inserted with a 377-bp probasin (Pbsn) RT-PCR fragment by T7 and SP6 primers to generate sense and antisense transcripts. Digoxigenin-labeled riboprobes were used, and the hybridization was performed using an automated in situ hybridization instrument Gen II (Ventana Medical System, Tucson, AZ). Detection and counterstaining were done with the BlueMap Kit (Ventana Medical System) and Nuclear Fast Red (Sigma-Aldrich).
Immunohistochemistry
Anti-calnexin-t (CLGN), a male germ cell developmental stage-specific protein, was immunostained by the method described previously [27] . Briefly, testes (n ¼ 3; left side) were fixed with Bouin solution and embedded in paraffin. Two different cross-sectional regions (4-lm thickness) from one testis were obtained (six sections from each group). Deparaffinized sections were incubated with anti-mouse calnexin-t antibody, followed by incubation with peroxidase-conjugated goat anti-mouse or rabbit IgG. After washing with PBS, immunoreactivity was detected with diaminobenzidine, followed by hematoxylin counterstaining. Morphometric measurement of the amount of CLGNpositive germ cells was carried out using AxioVision version 4.5 software (Carl Zeiss Co., Ltd., Oberkochen, Germany). The total area of seminiferous tubules within the 1-mm 2 area of the cross-sections from each genotype and treatment group was traced and summed. Then, the CLGN-positive cell numbers were counted and divided by the total area traced for the seminiferous tubules.
Testosterone Assay
Testicular testosterone levels were determined by the enzyme immunoassay (EIA) Kit (Cayman Chemical Co., Ann Arbor, MI). The frozen testis was homogenized in PBS, and the protein concentration was measured by the BCA Protein Assay Kit (Pierce Biotechnology, Inc., Rockford, IL). The homogenate was then extracted with diethyl ether, and the ether phase was air-dried. The dried lipophilic substances were resuspended in the appropriate volume of EIA buffer, and the measurements were done according to the manufacturer's instructions.
Statistical Analysis
For statistical analysis, StatView for Windows version 5.0 (SAS Institute, Cary, NC) was used. All data were expressed relative to the means of the control groups. All results are represented as the mean 6 SE. Two-way ANOVA was used for comparison of a given parameter among three control groups (Ahr þ=þ , Ahr þ=À , Ahr À=À ), followed by the Fisher PLSD post hoc test. P , 0.05 was considered significant.
AHR AND THE MALE REPRODUCTIVE SYSTEM
RESULTS
Reproductive Outcome
The number, body weight, and crown-anal length of male pups in each genotype on PND14 are represented in Table 1 . There were no statistically significant differences in body weight or crown-anal length among the three genotypes, or between control and TCDD-exposed groups. The number of Ahr þ=þ male pups exposed to TCDD was only six, which was much lower than the number of control pups, probably due to the fetal death by TCDD exposure in this genotype. Anogenital distance of Ahr þ=þ and Ahr þ=À male pups in the TCDDexposed groups was significantly reduced compared to control groups (P ¼ 0.016 and P ¼ 0.001, respectively). In contrast, the anogenital distance of Ahr À=À mice was not significantly different between TCDD-exposed and control mice. ANOVA did not reveal any significant differences in the mean anogenital distance among the three genotypes.
Gene Expressions in UGC
Quantitative RT-PCR analysis of the UGC on PND14 showed that Ahr mRNA was detected in Ahr þ=þ and Ahr þ=À mice but not in the Ahr À=À mice. The expression level in the Ahr þ=þ group was 2-fold higher than that in the Ahr þ=À mice, suggesting Ahr is transcribed from both alleles in the wild-type mice (Fig. 1) . Cyp1a1, Cyp1a2, and Cyp1b1 mRNAs, biomarkers of dioxin exposure, were not induced by TCDD 
in the Ahr
À=À mice, but were significantly upregulated in Ahr þ=þ and Ahr þ=À mice. In Ahr þ=þ and Ahr þ=À mice, the Cyp1b1 expression level in the TCDD-exposed group was higher than that in the control group (Fig. 1) . Although a slight decrease of Ar mRNA was seen in the Ahr þ=þ mice (TCDD exposed), we did not detect any significant change in Ar and Srd5a2 mRNA levels among the three TCDD-exposed genotypes. Pbsn (dorsolateral), Sbp (ventral), and Msmb (lateral) were used to investigate functional cytodifferentiation levels of each prostatic epithelia, as reported by others [28] . These three prostate markers were expressed in the control UGCs on PND14. They were barely detectable in TCDD-exposed Ahr þ=þ and Ahr þ=À mice, while TCDD-exposed Ahr À=À mice had quantities of these three marker mRNAs that were very similar to control mice (Fig. 1) .
Histopathology of the Urogenital Complex
Prostatic lobes were found to be well developed in the control animals (Fig. 2, A and D) . In the TCDD-exposed Ahr þ=þ animals, the prostatic lobes with existing epithelial layers were clearly observed (Fig. 2, B , C, E, and F). In situ hybridization analysis of the tissue section adjacent to the sections used for histopathological examinations revealed that epithelial cells of dorsolateral prostate lobes had Pbsn mRNA signals (Fig. 3A) . In accordance with the RT-PCR data, no signals were detected in the epithelia of TCDD-exposed dorsolateral prostates (Fig. 3C ).
Gene Expressions in Testis
Consistent with the analysis of UGC (Fig. 1) , the expression of Ahr mRNA was not detected in the Ahr À=À testis, whereas the Ahr expression level was 2-fold higher in the Ahr þ=þ than in the Ahr þ=À mice. No differences were detected in Ar mRNA levels (Fig. 4) . Among the three CYP1 genes tested, Cyp1a1 mRNA was not detected in any of the Ahr genotypes (data not shown). Although Cyp1a2 and Cyp1b1 mRNA was detected in the testis, there were no statistically significant differences among the three genotypes and between the control and TCDDexposed testes (Fig. 4) . The mRNA of CLGN and Hspa2, male germ cell-specific markers expressed in the pachytene stage of spermatocytes [29, 30] , was observed at the same levels among the three genotypes, regardless of TCDD exposure (Fig. 4) . No difference was observed in the expression level of Shbg, a protein secreted from Sertoli cells [31] . RNA expression levels of four steroidogenic enzyme genes for testosterone synthesis, Cyp11a1, Cyp17a1, Hsd3b1, and Hsd17b3, were not affected in the three genotypes under the TCDD dosing regimen used (Fig. 4) . Consistently, intratesticular testosterone levels in all genotypes and TCDD-exposed animals were not changed among the three genotypes, regardless of TCDD exposure (Table 1) . Additionally the mRNA of Akr1c4 and Srd5a1 enzymes for synthesis of 5a-androstane-3a, 17b-diol, the major form of testicular androgen in immature mice [32] , was not altered by TCDD exposure and showed no differences among the three genotypes in the testes (Fig. 4) . UGCs (A and D, control; B, C, E, and F, TCDD-exposed). Note that control mice had well-developed prostatic lobes on PND14 (A). Fewer layers of epithelial cells and increased cell numbers in mesenchymal cells were observed in the dorsolateral prostate lobe of TCDD-exposed animals compared to controls (E and F). Asterisks, seminal vesicle; arrows, dorsolateral prostate; U, urethra. Bars ¼ 500 lm (A, B, and C), 50 lm (D, E, and F).
FIG. 3. In situ hybridization analysis of
Pbsn mRNA expression in the dorsolateral prostate lobe of Ahr þ/þ mouse UGCs on PND14. A) Antisense probe for control mouse. B) Sense probe for control mouse. C) Antisense probe for TCDD-exposed mouse. Note that epithelial cells of the dorsolateral prostate lobes show Pbsn mRNA signals in control mice (A), but not in TCDD-exposed mice (C). Bar ¼ 200 lm.
Histopathology of the Testis
Spermatocytes at the pachytene stage proliferate from the spermatogonium on PND14, and calnexin-t is expressed at this stage [33] . In the present study, germ cells from the three mouse genotypes were immunostained for calnexin-t (Fig. 5 , A-C). Positive cell populations were similar in control and TCDD-exposed testes from all genotypes (Fig. 5, D-F) .
DISCUSSION
Ahr-Dependent Reduction in Anogenital Distance and Impairment of Prostatic Development by In Utero and Lactational TCDD Exposure
In this study, we demonstrated that in utero and lactational TCDD exposure caused reduction of the anogenital distance and impairment of prostatic development in an Ahr-dependent manner, because reduction of anogenital distance and disappearance of prostatic epithelial protein mRNAs were observed in Ahr þ=þ and Ahr þ=À but not in the Ahr À=À offspring. The induction of Cyp1a1 and Cyp1b1 mRNAs was also observed in Ahr þ=þ and Ahr þ=À mice but not in Ahr À=À mice. Taken together, impairment to the male reproductive system by in utero and lactational TCDD exposure was mainly dependent on the fetal Ahr gene.
A study using Ahr knockout mice that produced results similar to ours has been reported [17] . In that study, Ahr þ=À female and Ahr þ=À male mice were mated, and TCDD (5 lg/ kg) was injected into the pregnant mice on GD13. The levels of prostatic protein markers were reduced in the TCDD-exposed Ahr þ/þ mice on PND90, but not in the Ahr À=À mice. Furthermore, those authors reported that TCDD administration on GD13 severely inhibited prostatic bud formation from the urogenital sinus in the fetus [28] . The use of in an vitro organ culture system as well as Ahr knockout mice revealed that the inhibition was mediated by AHR expressed in the mesenchy- testis. E) TCDD-exposed Ahr þ=À testis. F) TCDD-exposed Ahr À=À testis. CLGN-positive spermatocytes were observed in all genotypes and TCDD-treatment groups. G) Morphometric analysis. There were no statistical differences in the number of positive cells per testis cross section, for all genotypes and treatments. Bar ¼ 100 lm. 640 mal cells of the urogenital sinus [34] and was not caused by interruption of androgen signaling in this tissue [35] . It is still unclear how TCDD impairs the responsiveness of the developing prostate to androgen.
In Utero and Lactational TCDD Exposure Decreased Androgen Responsiveness of the Prostate
In the histological examinations, the prostatic lobes developed with obvious epithelial layers in TCDD-exposed Ahr þ=þ mice, indicating TCDD-exposed prostates may function as normal exocrine glands (Fig. 2, B and C) . However, using RT-PCR and in situ hybridization analyses, we could not detect prostatic epithelial secretory protein mRNAs in the TCDD-exposed UGCs (Figs. 1 and 3) . Fewer layers of epithelial cells and increased cell numbers in mesenchymal cells were observed in the TCDD-exposed Ahr þ=þ animals, suggesting that in utero and lactational exposure to TCDD produced functional abnormalities (Fig. 2, E and F) . The prostatic secretory proteins, PBSN, MSMB, and SBP, were reportedly upregulated via the androgen receptor [36] [37] [38] . Since no significant differences in intratesticular testosterone levels were found between control and TCDD-exposed animals on PND14, we speculated that abnormal development of prostate glands may be due to decreased androgen sensitivity or that TCDD disrupts mouse prostate epithelial cell differentiation into luminal epithelial cells. This notion is consistent with a previous study [9] in the sense that the ventral prostate of male rat offspring exposed to TCDD in utero and via lactation did not respond to the exogenous androgens testosterone, 5a-dihydrotestosterone (DHT), and 5a-androstane-3a, 17b-diol, in the organ culture system. Administration of the androgen receptor antagonist flutamide and the 5a-reductase inhibitor finasteride to rats in the late pregnancy period did not cause prostate growth in male offspring on PND60 [39] , suggesting that DHT is an essential steroid hormone for prostate development. Since the inhibition was found specifically in the prostate but not in the seminal vesicle, the reduction in DHT production in the prostate was initially hypothesized to occur in males exposed to TCDD in utero and via lactation. However, 5a-reductase type 2 enzymatic activity and mRNA expression was elevated, compared to control groups [9, 10] . Thus, it is reasonable to speculate that decreased androgen responsiveness in the TCDD-exposed offspring was caused by other factors. Our previous study using Holtzman rats showed significantly reduced androgen receptor mRNA expression in the ventral prostate following in utero and lactational TCDD exposure, suggesting that the decreased androgen responsiveness might be due to reduced amounts of receptor molecules [10] . However, we could not detect a significant reduction in androgen receptor mRNA here, probably due to a difference in animal species or organs used for RT-PCR analysis.
Function of AHR in the Testis
AHR was reportedly responsible for apoptotic signaling, and the number of primordial cells in the ovarian germ line was not attenuated due to a defect in the apoptosis in Ahr-null female mice [20] . More recently, testicular dysfunction was reported in aged Ahr-null mice [40] , and HSD3B1 expression in Leydig cells was significantly reduced at 24 wk, resulting in serum testosterone decline, lowered sperm number, and reduced size of seminal vesicles. AHR seems to play a role in maintaining normal steroidogenesis in aged animals. However, in that study, there were no significant differences in testicular functions between wild-type and Ahr-null mice during younger stages (10 wk old). In our present study, we were unable to find differences in testicular functions among the Ahr genotypes, including testosterone production, Sertoli cell differentiation, and spermatogenic cell differentiation. Therefore, it is reasonable to conclude that AHR has very little function in early stages of gonad development. If the AHR functions even at the early stage of development, the functional redundancy with other genes may also exist among Ahr and other genes during testicular development.
Resistance of Testicular Development to In Utero and Lactational TCDD Exposure
In our previous study, TCDD administration to pregnant Holtzman rats on GD15 did not alter the testicular weight or serum testosterone levels of male offspring on PND49 [10] . In our present study, we did not find any differences in testicular cell differentiation levels between control Ahr-carrying animals and TCDD-exposed animals that survived the high dose of TCDD exposure, including supporting cell marker and spermatogenic cell differentiation markers, which suggested that even in the TCDD-exposed animals testicular differentiation proceeded normally. 5a-androstane-3a, 17b-diol, the major form of testicular androgen in immature mice [32] , was previously reported to be slightly reduced in PND21 mice perinatally exposed to TCDD [17] . However, in our present study, in the assayed testes from PND14, no difference was seen in both Akr1c4 and Srd5a1 mRNA expression levels among the three genotypes and TCDD treatment. Moreover, in utero and lactational exposure to TCDD did not alter the expression levels of steroidogenic enzyme genes in Leydig cells in Ahr þ=þ and Ahr þ=À animals. At a relatively high dose, testicular CYP11A1 activity was reduced by TCDD exposure [41] . In our previous report, we also found that administration of 100 lg TCDD/kg to adult male mice reduced testicular Cyp11a1 mRNA and protein levels [42] , and in vitro co-planer PCB (3, 3 0 ,4,4 0 ,5-pentachlorobiphenyl; PCB126) exposure to neonatal mouse testis downregulated Cyp11a1 mRNA expression [33] . The reason why we could not detect the reduction in Cyp11a1 mRNA in the present study is not clear, but it is speculated that intratesticular levels of TCDD in male pups born to dams given TCDD on GD13 was not sufficient to downregulate Cyp11a1 by PND14.
Although testes and UGCs were collected from the same individual pups, both Cyp1a2 and Cyp1b1 mRNAs were not induced in the testes of mice with any of the three genotypes, whereas in the UGCs, Cyp1a2 and Cyp1b1 were significantly induced. Moreover, an approximately 30-fold increase in Cyp1a1 was observed in the Ahr þ=þ UGCs. Thus, UGCs are much more sensitive to TCDD than testis in terms of Cyp1a1 mRNA induction. Using a xenobiotic-responsive element connected to the b-galactocidase reporter gene, a transgenic mouse line was generated and then exposed to TCDD in utero and via lactation [43] . X-Gal staining analysis clearly demonstrated that fetal urogenital tracts showed significant induction of the reporter gene, but that the testis did not respond. Based on the above-mentioned results, we speculated that UGCs express modulating factors (modifiers) that enhance AHR-mediated transcription, and that these were lacking or present in small amounts in the testis. Although it cannot be excluded that tissue concentration of TCDD in the testis was lower than that in the UGC, it is more likely that the testis is much more resistant to TCDD exposure than the UGC.
In conclusion, using Ahr knockout mice, we confirmed that in utero exposure to TCDD caused Ahr-dependent impairment of prostate development and reduced anogenital distances in AHR AND THE MALE REPRODUCTIVE SYSTEM male offspring, but that the testicular development seemed to be resistant to TCDD exposure. AHR was not associated with testicular development under physiological conditions.
